Prot #VX24-548-112: A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Project: Research project

Project Details

StatusActive
Effective start/end date1/30/25 → 1/29/28

Funding

  • Vertex Pharmaceuticals Incorporated (Prot #VX24-548-112)